Grace Therapeutics, Inc.
GRCE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444192
In the last 90 days, Grace Therapeutics, Inc. insiders filed 5 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Grace Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 12 | 9 | −3 |
| Shares | 558.3K | 571.3K | +13.0K (+2.3%) |
| Value | $1.55M | $1.65M | +$99.0K (+6.4%) |
New holders (3)
Institutions that held Grace Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 34,532 | $99.8K | 0.04% |
| Advisory Services Network, LLC | 41 | $118 | 0.00% |
| ICA Group Wealth Management, LLC | 9 | $26 | 0.00% |
Sold out (6)
Institutions that held Grace Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| TD Private Client Wealth LLC | 40,132 | $110.0K |
| Coastal Bridge Advisors, LLC | 10,000 | $27.8K |
| JPMorgan Chase & Co | 3,358 | $9.20K |
| Impact Partnership Wealth, LLC | 10 | $28 |
| TD Waterhouse Canada Inc. | 1 | $4 |
| NBC Securities, Inc. | 2 | $0 |